Flexion Therapeutics to Present at the Wells Fargo 2021 Virtual Healthcare Conference
Flexion Therapeutics (Nasdaq:FLXN) announced that Dr. Michael Clayman, President and CEO, will participate in an analyst-led fireside chat at the Wells Fargo 2021 Virtual Healthcare Conference. The chat is set for September 9, 2021, at 4:35 p.m. ET. Interested individuals can access the live webcast on the Flexion website.
Flexion Therapeutics focuses on innovative, localized treatments for musculoskeletal conditions, particularly osteoarthritis, the most prevalent form of arthritis.
- None.
- None.
BURLINGTON, Mass., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Wells Fargo 2021 Virtual Healthcare Conference. The virtual fireside chat is scheduled to begin at 4:35 p.m. ET on Thursday, September 9, 2021.
To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.
Contact:
Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com
FAQ
When is the Flexion Therapeutics fireside chat at the Wells Fargo Virtual Healthcare Conference?
Who will represent Flexion Therapeutics at the Wells Fargo Conference?
How can I access the Flexion Therapeutics webcast?
What is the main focus of Flexion Therapeutics?
